Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling

Xu,Jun; Yi,Yu; Li,Lin; Zhang,Weiguo; Wang,Jianhua

doi:10.3892/mmr.2015.3975

Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling

Authors:
- Jun Xu
- Yu Yi
- Lin Li
- Weiguo Zhang
- Jianhua Wang
View Affiliations

Affiliations: Department of Orthopedic Surgery, Wuhan Central Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Neurology, Wuhan Central Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P.R. China
Published online on: June 22, 2015 https://doi.org/10.3892/mmr.2015.3975
Pages: 4708-4712

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression of osteopontin (OPN) and vascular endothelial growth factor (VEGF) are associated with the severity of cartilage destruction in osteoarthritis. However, the biological connection between OPN and VEGF in osteoarthritis remains to be elucidated. The present study was performed to investigate the effect of OPN on VEGF expression in articular cartilage. Rat articular chondrocytes were isolated and cultured in monolayer conditions, and they were treated with OPN for different time periods (0, 2, 8, 12 or 24 h) and dosages (0, 0.1, 0.25 or 0.5 µM). VEGF expression was assessed by reverse transcription‑quantitative polymerase chain reaction and western blotting. The activation of the phosphoinositide 3‑kinase (PI3K)/AKT and extracellular signal‑regulated kinase (ERK)1/2 pathway was analyzed by detecting the expression of pPI3K, pAKT and pERK1/2. To inhibit the PI3K/AKT and ERK1/2 pathway, LY294002 and PD98059 were used, respectively or in combination. It was identified that OPN increased the expression of VEGF in a dose‑ and time‑dependent manner. The PI3K/AKT and ERK1/2 pathways were activated following OPN stimulation and the effect was concomitant with the upregulation of VEGF. Finally, the regulation of VEGF was inhibited by LY294002 and PD98059, and their combination exhibited a synergistic effect. In conclusion, these findings suggest that OPN may directly upregulate VEGF expression through the PI3K/AKT and ERK1/2 pathway. Further studies are required to reveal the mechanism of action of OPN on cartilage angiogenesis and cartilage destruction.

View Figures

View References

1	Gonzalez A: Osteoarthritis year 2013 in review: Genetics and genomics. Osteoarthritis Cartilage. 21:1443–1451. 2013. View Article : Google Scholar : PubMed/NCBI
2	Barg A, Pagenstert GI, Hugle T, Gloyer M, Wiewiorski M, Henninger HB and Valderrabano V: Ankle osteoarthritis: Etiology, diagnostics and classification. Foot Ankle Clin. 18:411–426. 2013. View Article : Google Scholar : PubMed/NCBI
3	Sandell LJ: Etiology of osteoarthritis: Genetics and synovial joint development. Nat Rev Rheumatol. 8:77–89. 2012.PubMed/NCBI
4	Soder S and Aigner T: Osteoarthritis. Etiology, typing, staging and histological grading. Pathologe. 32:183–192. 2011.In German.
5	Michael JW, Schluter-Brust KU and Eysel P: The epidemiology, etiology, diagnosis and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 107:152–162. 2010.PubMed/NCBI
6	Bara JJ, Johnson WE, Caterson B and Roberts S: Articular cartilage glycosaminoglycans inhibit the adhesion of endothelial cells. Connect Tissue Res. 53:220–228. 2012. View Article : Google Scholar
7	Hyc A, Osiecka-Iwan A, Jóźwiak J and Moskalewski S: The morphology and selected biological properties of articular cartilage. Ortop Traumatol Rehabil. 3:151–162. 2001.
8	Ashraf S, Mapp PI and Walsh DA: Contributions of angiogenesis to inflammation, joint damage and pain in a rat model of osteoarthritis. Arthritis Rheum. 63:2700–2710. 2011. View Article : Google Scholar : PubMed/NCBI
9	Pesesse L, Sanchez C and Henrotin Y: Osteochondral plate angiogenesis: A new treatment target in osteoarthritis. Joint Bone Spine. 78:144–149. 2011. View Article : Google Scholar
10	Mapp PI and Walsh DA: Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 8:390–398. 2012. View Article : Google Scholar : PubMed/NCBI
11	Wang QY, Dai J, Kuang B, Zhang J, Yu SB, Duan YZ and Wang MQ: Osteochondral angiogenesis in rat mandibular condyles with osteoarthritis-like changes. Arch Oral Biol. 57:620–629. 2012. View Article : Google Scholar : PubMed/NCBI
12	Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, et al: Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: A novel therapeutic strategy for angiogenesis. J Biol Chem. 285:5532–5540. 2010. View Article : Google Scholar :
13	Lingaraj K, Poh CK and Wang W: Vascular endothelial growth factor (VEGF) is expressed during articular cartilage growth and re-expressed in osteoarthritis. Ann Acad Med Singapore. 39:399–403. 2010.PubMed/NCBI
14	Jansen H, Meffert RH, Birkenfeld F, Petersen W and Pufe T: Detection of vascular endothelial growth factor (VEGF) in moderate osteoarthritis in a rabbit model. Ann Anat. 194:452–456. 2012. View Article : Google Scholar : PubMed/NCBI
15	Yamairi F, Utsumi H, Ono Y, Komorita N, Tanaka M and Fukunari A: Expression of vascular endothelial growth factor (VEGF) associated with histopathological changes in rodent models of osteoarthritis. J Toxicol Pathol. 24:137–142. 2011. View Article : Google Scholar
16	Murata M, Yudoh K and Masuko K: The potential role of vascular endothelial growth factor (VEGF) in cartilage: How the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage. 16:279–286. 2008. View Article : Google Scholar
17	Matsumoto T, Cooper GM, Gharaibeh B, Meszaros LB, Li G, Usas A, Fu FH and Huard J: Blocking VEGF as a potential approach to improve cartilage healing after osteoarthritis. J Musculoskelet Neuronal Interact. 8:316–317. 2008.
18	Rangaswami H, Bulbule A and Kundu GC: Osteopontin: Role in cell signaling and cancer progression. Trends Cell Biol. 16:79–87. 2006. View Article : Google Scholar : PubMed/NCBI
19	Chakraborty G, Jain S, Behera R, Ahmed M, Sharma P, Kumar V and Kundu GC: The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr Mol Med. 6:819–830. 2006. View Article : Google Scholar : PubMed/NCBI
20	Gao SG, Li KH, Zeng KB, Tu M, Xu M and Lei GH: Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis Cartilage. 18:82–87. 2010. View Article : Google Scholar
21	Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M and Yuktanandana P: Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem. 42:808–812. 2009. View Article : Google Scholar : PubMed/NCBI
22	Xu M, Zhang L, Zhao L, Gao S, Han R, Su D and Lei G: Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13. Rheumatol Int. 33:1313–1319. 2013. View Article : Google Scholar
23	Chen Q, Liu SQ, Du YM, Peng H and Sun LP: Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis. Eur J Pharmacol. 541:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
24	Ashraf S and Walsh DA: Angiogenesis in osteoarthritis. Curr Opin Rheumatol. 20:573–580. 2008. View Article : Google Scholar : PubMed/NCBI
25	Mapp PI, Avery PS, McWilliams DF, Bowyer J, Day C, Moores S, Webster R and Walsh DA: Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage. 16:61–69. 2008. View Article : Google Scholar
26	Chen XY, Hao YR, Wang Z, Zhou JL, Jia QX and Qiu B: The effect of vascular endothelial growth factor on aggrecan and type II collagen expression in rat articular chondrocytes. Rheumatol Int. 32:3359–3364. 2012. View Article : Google Scholar
27	Das R, Mahabeleshwar GH and Kundu GC: Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem. 278:28593–28606. 2003. View Article : Google Scholar : PubMed/NCBI
28	Jain S, Chakraborty G and Kundu GC: The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res. 66:6638–6648. 2006. View Article : Google Scholar : PubMed/NCBI
29	Cao Z, Dai J, Fan K, Wang H, Ji G, Li B, Zhang D, Hou S, Qian W, Zhao J, et al: A novel functional motif of osteopontin for human lymphocyte migration and survival. Mol Immunol. 45:3683–3692. 2008. View Article : Google Scholar : PubMed/NCBI